Allergy/Asthma News

In this video, Priya J. Bansal, MD, FAAAAI, FACAAI, introduces Healio’s Women in Allergy and the video corner, where she will share regular pearls, advice and updates.

WASHINGTON — Single maintenance and reliever therapy was not commonly initiated by primary care providers, although PCPs supported efforts to improve adoption, a study showed.

The number one financial goal for most doctors is, by far, getting to a comfortable retirement on their own timeline and with the lifestyle they want.

Healio has compiled February’s most-read news in asthma and allergy.

WASHINGTON — Patients with moderate to severe atopic dermatitis treated with lebrikizumab maintained improvements in patient-reported outcomes, according to a poster presented here.

WASHINGTON — Omalizumab increased thresholds for reacting to peanut and other common allergenic foods during accidental exposure, according to a study presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Jennifer Namazy, MD, FAAAAI, credits many of her achievements to the mentors she had in her early career. Now as a professor of clinical medicine at Scripps Clinic Medical Group, she gets to be a mentor to a new generation of allergists.

Payel Gupta, MD, FACAAI, says the busier she is, the more efficient she is, which may explain how she is able to balance caring for patients, running a company, hosting a podcast and teaching.

Healio has launched Women in Allergy, an initiative that aims to advance the work of women in allergy by providing insights for overcoming challenges and assistance in achieving better health care.

WASHINGTON — Patients with atopic dermatitis may have better outcomes when using liquid synthetic detergents, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.